IV Infusion Therapy
In bypassing the digestive system, a much higher level of nutrition is delivered directly to your cells. This is especially important in those who are experiencing digestive and/or chronic health issues. Many reasons to get an IV are:
• Adjunctive cancer care support
• Fatigue due to stress
• Immune boosting
• Crohn’s and ulcerative colitis
• Migraines & tension headaches
• Chronic or acute muscle spasms
• Parkinson's disease
• Macular degeneration
• Chronic fatigue
• Chronic disease
Variations of the Meyers’ cocktail will be used for the majority of conditions. It is named after John Myers, M.D., a Maryland physician who used intravenous injections of nutrients to treat many chronic conditions. He found that increasing the blood concentration of several essential vitamins and minerals beyond that which can be achieved when supplementing orally. For example, vitamin C given intravenously has been found to reach blood concentrations more than 50 times greater than what can be achieved when given orally.
For adjunctive cancer care, intravenous vitamin C (IVC) is a powerful pairing with conventional treatment. As a oral supplement or even in low doses in IV, vitamin C acts as an antioxidant. However, in the high dose vitamin C intravenous drips, vitamin C acts as a pro-oxidant. A prooxidant is similar to how some chemotherapeutics work in killing cancer cells. What makes IVC unique is that it only targets cancer cells and does not negatively impact your normal, healthy cells. In a retrospective study it was found that treatment of breast cancer patients with
intravenous vitamin C resulted in a significant reduction of complaints induced by the disease and chemotherapy/radiotherapy, in particular of nausea, loss of appetite, fatigue, depression, sleep disorders, dizziness and tendency to bleed due to coagulation issues1. It was shown to be a well tolerated, safe and improved quality of life.
1. Vollbract C et al. Intravenous Vitamin C Administration Improves Quality of Life in Breast Cancer Patients during Chemo-/Radiotherapy and Aftercare: Results of a Retrospective, Multicentre, Epidemiological Cohort Study in Germany. in vivo (2011) 25: 983-99